Role of interventional therapy in hepatic artery stenosis and non-anastomosis bile duct stricture after orthotopic liver transplantation

Table 1 General data pertaining to patients with HAS and non-stoma bile duct stricture

Case	Sex	Age	Primary disease	Hepatic artery			Bile duct
				Anastomosis Manifestation Time afterOLT (mo)			Anastomosis Manifestation Time afterOLT (mo)
1	M	41	Hepatic cirrhosis	End-to-end	Stoma stricture	6	End-to-end	Diffuse stricture	7
2	M	51	HCC	End-to-end	Stoma stricture	3	End-to-end	Diffuse stricture	4
3	M	42	Hemangiomas	End-to-end	Stoma stricture	4 d	End-to-end	Diffuse stricture	10
4	M	32	Hepatic cirrhosis	End-to-end	Stoma stricture	2	End-to-end	Diffuse stricture	21
5	M	65	HCC	End-to-end	HA occlusion	15	End-to-end	Diffuse stricture	17
6	M	37	Hepatic cirrhosis	End-to-end	Stoma stricture	12	End-to-end	Diffuse stricture	15
7	M	40	Re-hepatitis	Bypass	Stoma stricture	3	R-Y	Diffuse stricture	4
8	F	59	Re-hepatitis	Bypass	Stoma stricture	1	R-Y	Diffuse stricture	3
9	M	39	Hepatic cirrhosis	End-to-end	Stoma stricture	9	End-to-end	Diffuse stricture	11

HCC: Hepatocellular carcinoma; Re-hepatitis: Recurrent hepatitis; R-Y: Roux-en-Y anastomosis.

Table 2 Results of intervention therapy in patients with HAS and ITBL

Case	Hepatic artery				Bile duct				Survival/Follow-upperiod (mo)
	Time afterOLT (mo)	Treatmen	Frequency	Outcome	Time afterOLT (mo)	Treatment	Frequency	Outcome
1	6	Stent	1	Disengaged (stent occlusion 3 mo later)	7	PTBD	1	Smooth drainage	21
2	8	Stent	1	Disengaged	8	PTBD/balloon	4/2	Smooth drainage	17
3	4 d	Stent	1	Disengaged	10	Stent/PTBD	1/4	Removal 5 mo later	18
4	2	Balloon	1	Disengaged	21	PTBD	3	Smooth drainage	30
5	15	Expectant	0	Occlusion	17	PTBD/balloon	3/2	Smooth drainage	23/died of liver failure
6	12	Expectant	0	Stricture	15	PTBD/balloon	1/1	Smooth drainage	18
7	3	Expectant	0	Stricture	4	PTBD	2	Smooth drainage	6
8	1	Expectant	0	Stricture	3	PTBD/balloon /bile mud removal	8/1	Smooth drainage	9/third OLT
9	10	Expectant	0	Stricture	11	PTBD/balloon	2/1	Smooth drainage	13